Aprecia to snap up to $30 mln from Hercules

Hercules Capital has agreed to provide up to $30 million in debt funding to Aprecia Pharmaceuticals Company, a maker of fast melt pharmaceutical products. Armentum Partners provided financial advice to Aprecia on this transaction.

5 July 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail